Llwytho...
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
Non-small cell lung cancer (NSCLC) remains the most prevalent and one of the deadliest cancers worldwide. Despite recent success, there is still an urgent need for new therapeutic strategies. It is also becoming increasingly evident that combinatorial approaches are more effective than single modali...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pharmaceuticals (Basel) |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
MDPI
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7700219/ https://ncbi.nlm.nih.gov/pubmed/33266470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13110413 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|